A detailed history of Rialto Wealth Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Rialto Wealth Management, LLC holds 76 shares of RCKT stock, worth $304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 91 16.48%
Holding current value
$304
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$2.33 - $8.01 $34 - $120
-15 Reduced 16.48%
76 $0
Q1 2025

Apr 10, 2025

BUY
$6.67 - $12.72 $606 - $1,157
91 New
91 $0

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $303M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Rialto Wealth Management, LLC Portfolio

Follow Rialto Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rialto Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rialto Wealth Management, LLC with notifications on news.